These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 15300237)
21. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752 [TBL] [Abstract][Full Text] [Related]
22. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Peehl DM; Skowronski RJ; Leung GK; Wong ST; Stamey TA; Feldman D Cancer Res; 1994 Feb; 54(3):805-10. PubMed ID: 7508338 [TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
24. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599 [TBL] [Abstract][Full Text] [Related]
25. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells. Golovko O; Nazarova N; Tuohimaa P Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
27. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183 [TBL] [Abstract][Full Text] [Related]
28. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells. Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364 [TBL] [Abstract][Full Text] [Related]
30. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2. Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781 [TBL] [Abstract][Full Text] [Related]
31. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate. Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728 [TBL] [Abstract][Full Text] [Related]
32. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
33. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach. Kriebitzsch C; Verlinden L; Eelen G; Tan BK; Van Camp M; Bouillon R; Verstuyf A Anticancer Res; 2009 Sep; 29(9):3471-83. PubMed ID: 19667141 [TBL] [Abstract][Full Text] [Related]
34. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. Trtková K; Pašková L; Matiješčuková N; Kolář Z Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266 [TBL] [Abstract][Full Text] [Related]
35. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946 [TBL] [Abstract][Full Text] [Related]
36. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790 [TBL] [Abstract][Full Text] [Related]
37. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. Malinen M; Saramäki A; Ropponen A; Degenhardt T; Väisänen S; Carlberg C Nucleic Acids Res; 2008 Jan; 36(1):121-32. PubMed ID: 17999998 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5. Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524 [TBL] [Abstract][Full Text] [Related]
39. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Moffatt KA; Johannes WU; Miller GJ Clin Cancer Res; 1999 Mar; 5(3):695-703. PubMed ID: 10100724 [TBL] [Abstract][Full Text] [Related]
40. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]